L'Oreal US settles hair relaxer cancer cases during first trial
The confidential deal ends the first trial over claims that chemical hair straighteners caused gynecologic cancers, lawyers said.
- On Monday, four women settled their lawsuit against Oreal USA in Chicago, resolving claims that chemical hair relaxers caused them to develop cancer.
- More than 12,700 cases centralized in federal court involve lawsuits filed in 2023 and 2024, alleging years of using chemical hair straighteners led to gynecologic cancer diagnoses.
- A National Institutes of Health study linked products marketed under Dark and Lovely and Optimum brands to significantly increased uterine cancer risk in frequent users.
- Oreal maintains its products are safe despite the confidential settlement, stating, 'L'Oréal USA strictly follows all regulations in every market in which it operates.'
- Arizona and Minnesota also sued Oreal this year, alleging the company misled consumers about the safety of SoftSheen-Carson brand hair relaxers.
10 Articles
10 Articles
L'Oreal US settles hair relaxer cancer cases during first trial
Four women who said they were diagnosed with cancer as a result of chemical hair straightening products reached a settlement on Monday with L’Oreal's US subsidiary and other companies during a trial in Chicago, according to their attorneys.
L’Oreal U.S. settles hair relaxer cancer cases during first trial
Four women who said they were diagnosed with cancer as a result of chemical hair straightening products reached a settlement on Monday with L’Oreal’s subsidiary and other companies during a trial in Chicago.
A comparison could be concluded with four women. The amount of the comparison is confidential.
A lawsuit filed by women with cancer against a U.S. cosmetics giant has raised questions about the safety of hair care products. Four women who said they developed gynecological cancers after years of using chemical hair straightening products have reached an out-of-court settlement with the cosmetics giant's U.S. subsidiary and other companies in the first of several lawsuits in Chicago. The settlement, for an undisclosed amount, is part of a b…
In the dispute over a possible cancer risk from chemical hair straighteners, L-Oréal has concluded a comparison with four women in the USA. Thousands more lawsuits are pending.
Coverage Details
Bias Distribution
- 40% of the sources are Center, 40% of the sources lean Right
Factuality
To view factuality data please Upgrade to Premium











